The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. NeuroOne Medical Technologies Corp shares valued at $100,000 were purchased by McClurg Ronald W. on Apr 04 ’25. At $0.50 per share, McClurg Ronald W. acquired 200,000 shares. The insider’s holdings grew to 444,117 shares worth approximately $0.26 million following the completion of this transaction.
Also, Rosa David A purchased 100,000 shares, netting a total of over 50,000 in proceeds. Following the buying of shares at $0.50 each, the insider now holds 1,161,289 shares.
Before that, Christianson Mark had added 30,000 shares to its account. In a trade valued at $30,600, the Co-Founder, VP of Business Com bought NeuroOne Medical Technologies Corp shares for $1.02 each.
As published in a research note from Craig Hallum on March 29, 2022, NeuroOne Medical Technologies Corp [NMTC] has been rated down from a Buy to a Hold and the price target has been revised to $2 from $6.
Analyzing NMTC Stock Performance
During the last five days, there has been a surge of approximately 34.73%. Over the course of the year, NeuroOne Medical Technologies Corp shares have dropped approximately -29.82%. Shares of the company reached a 52-week high of $1.3900 on 01/24/25 and a 52-week low of $0.3954 on 04/09/25. A 50-day SMA is recorded $0.9226, while a 200-day SMA reached $0.8829.
Support And Resistance Levels for NeuroOne Medical Technologies Corp (NMTC)
According to the 24-hour chart, there is a support level at 0.5631, which, if violated, would cause prices to drop to 0.5465. In the upper region, resistance lies at 0.6031. The next price resistance is at 0.6265. RSI (Relative Strength Index) is 36.67 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.0351, which suggests the price will decrease in the coming days. Percent R is at 64.89%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
